Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07801664 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer

Name: Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer — clinical trial record (NCT07801664)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorNYU Langone Health

Started2026-08-06

View on ClinicalTrials.gov ↗

NYU Langone Health

394 trials monitored

See 18 trials at risk

Prostate Cancer

2,471 trials monitored

See 156 trials at risk

For this study, high risk prostate cancer patients with lower risk ARTERA scores will be treated with 6 months of Androgen Deprivation Therapy (ADT) in conjunction with dose escalated radiotherapy to the prostate and nodes. Specifically, patients enrolled in this study will undergo one of several dose-escalated forms of radiotherapy which would include SBRT with or without a brachytherapy boost.

Trial Details

NCT Number	NCT07801664
Lead Sponsor	NYU Langone Health
Conditions	Prostate Cancer
Enrollment	90 participants
Start Date	2026-08-06
Primary Completion	2028-08-01 (estimated)
Study Completion	2029-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-03